Annual CFF
$9.02 M
-$22.61 M-71.49%
December 31, 2023
Summary
- As of February 8, 2025, AXDX annual cash flow from financing activities is $9.02 million, with the most recent change of -$22.61 million (-71.49%) on December 31, 2023.
- During the last 3 years, AXDX annual CFF has fallen by -$2.61 million (-22.47%).
- AXDX annual CFF is now -92.83% below its all-time high of $125.77 million, reached on December 31, 2018.
Performance
AXDX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$14.80 M
+$13.41 M+960.46%
September 30, 2024
Summary
- As of February 8, 2025, AXDX quarterly cash flow from financing activities is $14.80 million, with the most recent change of +$13.41 million (+960.46%) on September 30, 2024.
- Over the past year, AXDX quarterly CFF has stayed the same.
- AXDX quarterly CFF is now -85.82% below its all-time high of $104.39 million, reached on December 31, 2015.
Performance
AXDX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$27.75 M
+$15.62 M+128.83%
September 30, 2024
Summary
- As of February 8, 2025, AXDX TTM cash flow from financing activities is $27.75 million, with the most recent change of +$15.62 million (+128.83%) on September 30, 2024.
- Over the past year, AXDX TTM CFF has stayed the same.
- AXDX TTM CFF is now -85.42% below its all-time high of $190.24 million, reached on March 31, 2018.
Performance
AXDX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AXDX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -71.5% | 0.0% | 0.0% |
| 3 y3 years | -22.5% | 0.0% | 0.0% |
| 5 y5 years | -92.8% | 0.0% | 0.0% |
AXDX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -79.1% | at low | -53.8% | +1912.0% | -45.2% | +215.8% |
| 5 y | 5-year | -79.1% | +32.2% | -53.8% | +1912.0% | -45.2% | +525.5% |
| alltime | all time | -92.8% | +4836.9% | -85.8% | +1912.0% | -85.4% | +9348.7% |
Accelerate Diagnostics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $14.80 M(+960.5%) | $27.75 M(+128.8%) |
| Jun 2024 | - | $1.40 M(-87.8%) | $12.13 M(-41.0%) |
| Mar 2024 | - | $11.44 M(>+9900.0%) | $20.54 M(+127.7%) |
| Dec 2023 | $9.02 M(-71.5%) | $107.00 K(-113.1%) | $9.02 M(+2.7%) |
| Sep 2023 | - | -$817.00 K(-108.3%) | $8.79 M(-78.9%) |
| Jun 2023 | - | $9.81 M(<-9900.0%) | $41.64 M(+32.3%) |
| Mar 2023 | - | -$77.00 K(-38.9%) | $31.48 M(-0.5%) |
| Dec 2022 | $31.63 M(-26.8%) | -$126.00 K(-100.4%) | $31.63 M(-37.5%) |
| Sep 2022 | - | $32.04 M(-9073.7%) | $50.65 M(+160.5%) |
| Jun 2022 | - | -$357.00 K(-563.6%) | $19.44 M(-38.2%) |
| Mar 2022 | - | $77.00 K(-99.6%) | $31.45 M(-27.2%) |
| Dec 2021 | $43.23 M(+271.6%) | $18.89 M(+2176.0%) | $43.23 M(+68.4%) |
| Sep 2021 | - | $830.00 K(-92.9%) | $25.68 M(-5.3%) |
| Jun 2021 | - | $11.65 M(-1.7%) | $27.10 M(+22.9%) |
| Mar 2021 | - | $11.86 M(+784.7%) | $22.06 M(+89.6%) |
| Dec 2020 | $11.63 M(+70.5%) | $1.34 M(-40.6%) | $11.63 M(+7.0%) |
| Sep 2020 | - | $2.25 M(-65.9%) | $10.87 M(+6.2%) |
| Jun 2020 | - | $6.61 M(+362.5%) | $10.24 M(+130.9%) |
| Mar 2020 | - | $1.43 M(+146.0%) | $4.44 M(-35.0%) |
| Dec 2019 | $6.82 M(-94.6%) | $581.00 K(-64.2%) | $6.82 M(+6.3%) |
| Sep 2019 | - | $1.62 M(+101.7%) | $6.42 M(+8.4%) |
| Jun 2019 | - | $804.00 K(-78.9%) | $5.92 M(-78.7%) |
| Mar 2019 | - | $3.82 M(+2080.6%) | $27.74 M(-77.9%) |
| Dec 2018 | $125.77 M(+39.1%) | $175.00 K(-84.4%) | $125.77 M(-1.5%) |
| Sep 2018 | - | $1.12 M(-95.0%) | $127.72 M(+0.1%) |
| Jun 2018 | - | $22.63 M(-77.8%) | $127.63 M(-32.9%) |
| Mar 2018 | - | $101.85 M(+4695.1%) | $190.24 M(+110.4%) |
| Dec 2017 | $90.43 M(+5032.1%) | $2.12 M(+106.0%) | $90.43 M(+1.5%) |
| Sep 2017 | - | $1.03 M(-98.8%) | $89.08 M(+0.3%) |
| Jun 2017 | - | $85.24 M(+4092.8%) | $88.78 M(+1832.4%) |
| Mar 2017 | - | $2.03 M(+161.0%) | $4.59 M(+160.7%) |
| Dec 2016 | $1.76 M(-98.3%) | $779.00 K(+7.6%) | $1.76 M(-98.3%) |
| Sep 2016 | - | $724.00 K(-31.6%) | $105.37 M(+0.5%) |
| Jun 2016 | - | $1.06 M(-232.4%) | $104.83 M(+0.8%) |
| Mar 2016 | - | -$799.00 K(-100.8%) | $103.99 M(-0.8%) |
| Dec 2015 | $104.82 M(+129.4%) | $104.39 M(>+9900.0%) | $104.82 M(>+9900.0%) |
| Sep 2015 | - | $178.00 K(-20.5%) | $589.00 K(+118.1%) |
| Jun 2015 | - | $224.00 K(+646.7%) | $270.00 K(-99.4%) |
| Mar 2015 | - | $30.00 K(-80.9%) | $45.00 M(-1.5%) |
| Dec 2014 | $45.69 M(+11.8%) | $157.00 K(-211.3%) | $45.69 M(-0.7%) |
| Sep 2014 | - | -$141.00 K(-100.3%) | $45.99 M(-30.7%) |
| Jun 2014 | - | $44.95 M(+6108.7%) | $66.38 M(+209.2%) |
| Mar 2014 | - | $724.00 K(+58.8%) | $21.47 M(-47.5%) |
| Dec 2013 | $40.88 M(>+9900.0%) | $456.00 K(-97.7%) | $40.88 M(+1.1%) |
| Sep 2013 | - | $20.25 M(>+9900.0%) | $40.42 M(+99.4%) |
| Jun 2013 | - | $40.00 K(-99.8%) | $20.28 M(-41.7%) |
| Mar 2013 | - | $20.14 M(>+9900.0%) | $34.79 M(+139.6%) |
| Dec 2012 | $100.00 K(-99.3%) | - | - |
| Oct 2012 | - | $100.00 K(-99.3%) | $14.52 M(-0.2%) |
| Jul 2012 | $14.55 M(>+9900.0%) | $14.55 M(>+9900.0%) | $14.55 M(+7384.1%) |
| Apr 2012 | - | $0.00(-100.0%) | $194.40 K(0.0%) |
| Jan 2012 | - | -$128.60 K(-200.0%) | $194.40 K(-39.8%) |
| Dec 2011 | $0.00(-100.0%) | - | - |
| Oct 2011 | - | $128.60 K(-33.8%) | $323.00 K(+66.2%) |
| Jul 2011 | $194.40 K | $194.40 K(>+9900.0%) | $194.40 K(>+9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2011 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Jul 2010 | $335.00 K(>+9900.0%) | $0.00(-100.0%) | $335.00 K(0.0%) |
| Apr 2010 | - | $335.00 K(>+9900.0%) | $335.00 K(>+9900.0%) |
| Jul 2009 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Apr 2009 | - | $0.00(0.0%) | $125.80 K(-86.4%) |
| Oct 2008 | - | $0.00(-100.0%) | $925.80 K(0.0%) |
| Jul 2008 | $925.80 K(>+9900.0%) | $125.80 K(-84.3%) | $925.80 K(+15.7%) |
| Apr 2008 | - | $800.00 K(>+9900.0%) | $800.00 K(>+9900.0%) |
| Jan 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jul 2007 | $0.00(0.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Apr 2007 | - | $0.00(0.0%) | -$281.70 K(<-9900.0%) |
| Jan 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2006 | - | $0.00(-100.0%) | $0.00(0.0%) |
| Jul 2006 | $0.00(0.0%) | -$281.70 K(-200.0%) | $0.00(-100.0%) |
| Apr 2006 | - | $281.70 K(>+9900.0%) | $281.70 K(>+9900.0%) |
| Jan 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jul 2005 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jan 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jul 2004 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Apr 2004 | - | $0.00(0.0%) | $110.00 K(-24.7%) |
| Jan 2004 | - | $0.00(0.0%) | $146.00 K(0.0%) |
| Oct 2003 | - | $0.00(-100.0%) | $146.00 K(0.0%) |
| Jul 2003 | $146.00 K(-300.5%) | $110.00 K(+205.6%) | $146.00 K(+493.5%) |
| Apr 2003 | - | $36.00 K(>+9900.0%) | $24.60 K(-188.2%) |
| Jan 2003 | - | $0.00(0.0%) | -$27.90 K(-52.6%) |
| Oct 2002 | - | $0.00(-100.0%) | -$58.80 K(-19.2%) |
| Jul 2002 | -$72.80 K(-30.1%) | -$11.40 K(-30.9%) | -$72.80 K(+18.6%) |
| Apr 2002 | - | -$16.50 K(-46.6%) | -$61.40 K(+29.3%) |
| Jan 2002 | - | -$30.90 K(+120.7%) | -$47.50 K(-55.6%) |
| Oct 2001 | - | -$14.00 K(<-9900.0%) | -$106.90 K(+2.6%) |
| Jul 2001 | -$104.10 K(+103.3%) | $0.00(-100.0%) | -$104.20 K(-3.2%) |
| Apr 2001 | - | -$2600.00(-97.1%) | -$107.70 K(+2.5%) |
| Jan 2001 | - | -$90.30 K(+699.1%) | -$105.10 K(+610.1%) |
| Oct 2000 | - | -$11.30 K(+222.9%) | -$14.80 K(-71.1%) |
| Jul 2000 | -$51.20 K(-73.1%) | -$3500.00(<-9900.0%) | -$51.20 K(+34.4%) |
| Apr 2000 | - | $0.00(0.0%) | -$38.10 K(-71.3%) |
| Jan 2000 | - | $0.00(-100.0%) | -$132.90 K(0.0%) |
| Oct 1999 | - | -$47.70 K(-596.9%) | -$132.90 K(-30.2%) |
| Jul 1999 | -$190.40 K(-163.5%) | $9600.00(-110.1%) | -$190.40 K(-36.5%) |
| Apr 1999 | - | -$94.80 K(<-9900.0%) | -$300.00 K(+80.7%) |
| Jan 1999 | - | $0.00(-100.0%) | -$166.00 K(-185.2%) |
| Oct 1998 | - | -$105.20 K(+5.2%) | $194.80 K(-35.1%) |
| Jul 1998 | $300.00 K(-95.2%) | -$100.00 K(-355.1%) | $300.00 K(0.0%) |
| Apr 1998 | - | $39.20 K(-89.1%) | $300.00 K(-16.9%) |
| Jan 1998 | - | $360.80 K(>+9900.0%) | $360.80 K(-94.2%) |
| Oct 1997 | - | $0.00(-100.0%) | $6.20 M(0.0%) |
| Jul 1997 | $6.20 M(>+9900.0%) | -$100.00 K(-200.0%) | $6.20 M(-1.6%) |
| Apr 1997 | - | $100.00 K(-98.4%) | $6.30 M(+1.6%) |
| Jan 1997 | - | $6.20 M(>+9900.0%) | $6.20 M(>+9900.0%) |
| Oct 1996 | - | $0.00 | $0.00 |
| Jul 1996 | $0.00 | - | - |
FAQ
- What is Accelerate Diagnostics annual cash flow from financing activities?
- What is the all time high annual CFF for Accelerate Diagnostics?
- What is Accelerate Diagnostics annual CFF year-on-year change?
- What is Accelerate Diagnostics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Accelerate Diagnostics?
- What is Accelerate Diagnostics quarterly CFF year-on-year change?
- What is Accelerate Diagnostics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Accelerate Diagnostics?
- What is Accelerate Diagnostics TTM CFF year-on-year change?
What is Accelerate Diagnostics annual cash flow from financing activities?
The current annual CFF of AXDX is $9.02 M
What is the all time high annual CFF for Accelerate Diagnostics?
Accelerate Diagnostics all-time high annual cash flow from financing activities is $125.77 M
What is Accelerate Diagnostics annual CFF year-on-year change?
Over the past year, AXDX annual cash flow from financing activities has changed by -$22.61 M (-71.49%)
What is Accelerate Diagnostics quarterly cash flow from financing activities?
The current quarterly CFF of AXDX is $14.80 M
What is the all time high quarterly CFF for Accelerate Diagnostics?
Accelerate Diagnostics all-time high quarterly cash flow from financing activities is $104.39 M
What is Accelerate Diagnostics quarterly CFF year-on-year change?
Over the past year, AXDX quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Accelerate Diagnostics TTM cash flow from financing activities?
The current TTM CFF of AXDX is $27.75 M
What is the all time high TTM CFF for Accelerate Diagnostics?
Accelerate Diagnostics all-time high TTM cash flow from financing activities is $190.24 M
What is Accelerate Diagnostics TTM CFF year-on-year change?
Over the past year, AXDX TTM cash flow from financing activities has changed by $0.00 (0.00%)